Teza Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,940
Closed -$272K 637
2024
Q1
$272K Buy
+3,940
New +$249K 0.04% 460
2023
Q3
Sell
-15,772
Closed -$1.48M 643
2023
Q2
$1.48M Buy
15,772
+12,797
+430% +$998K 0.24% 124
2023
Q1
$202K Sell
2,975
-11,544
-80% -$742K 0.04% 466
2022
Q4
$719K Sell
14,519
-9,214
-39% -$376K 0.14% 245
2022
Q3
$771K Buy
23,733
+18,318
+338% +$755K 0.16% 180
2022
Q2
$213K Buy
+5,415
New +$290K 0.08% 381
2021
Q4
Sell
-5,302
Closed -$506K 463
2021
Q3
$506K Buy
+5,302
New +$560K 0.24% 126
2020
Q2
Sell
-3,626
Closed -$210K 541
2020
Q1
$210K Sell
3,626
-403
-10% -$32.7K 0.67% 72
2019
Q4
$373K Sell
4,029
-4,572
-53% -$402K 0.1% 360
2019
Q3
$777K Buy
+8,601
New +$980K 0.2% 171

Other funds holding EXAS

Teza Capital Management's EXAS Position: Q2 2024 in Review

Teza Capital Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 3,940 shares — an estimated $272K sold.

Teza Capital Management first reported a position in EXAS in Q3 2019 and held it in 10 quarters. The position peaked at $1.48M in Q2 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Teza Capital Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Teza Capital Management sold 3,940 Exact Sciences shares in Q2 2024, an estimated $272K.
  • Teza Capital Management first reported a position in Exact Sciences in Q3 2019 and held it in 10 quarters.
  • Teza Capital Management's Exact Sciences position peaked at $1.48M in Q2 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Teza Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.